Albert Leung

4.1k total citations
44 papers, 3.1k citations indexed

About

Albert Leung is a scholar working on Molecular Biology, Oncology and Orthopedics and Sports Medicine. According to data from OpenAlex, Albert Leung has authored 44 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 21 papers in Oncology and 14 papers in Orthopedics and Sports Medicine. Recurrent topics in Albert Leung's work include Bone health and treatments (19 papers), Bone health and osteoporosis research (13 papers) and Ion channel regulation and function (11 papers). Albert Leung is often cited by papers focused on Bone health and treatments (19 papers), Bone health and osteoporosis research (13 papers) and Ion channel regulation and function (11 papers). Albert Leung collaborates with scholars based in United States, New Zealand and Belgium. Albert Leung's co-authors include Kevin P. Campbell, Alan H. Sharp, Toshiaki Imagawa, Philip Blazar, Brandon E. Earp, Maximillian Soong, Gavin Bishop, Anchi Cheng, Anna Hui and Mark E. Williams and has published in prestigious journals such as Science, New England Journal of Medicine and Journal of the American Chemical Society.

In The Last Decade

Albert Leung

41 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Albert Leung United States 24 2.2k 845 520 433 374 44 3.1k
Daniel E. Michele United States 33 3.5k 1.6× 625 0.7× 1.1k 2.2× 306 0.7× 95 0.3× 69 4.6k
Eva R. Chin United States 30 2.3k 1.1× 427 0.5× 596 1.1× 168 0.4× 57 0.2× 62 3.7k
Yoji Hakamata Japan 30 1.9k 0.9× 685 0.8× 356 0.7× 588 1.4× 191 0.5× 129 3.5k
Zhouguang Wang China 36 1.2k 0.5× 613 0.7× 96 0.2× 518 1.2× 82 0.2× 105 3.5k
Kunfu Ouyang China 33 3.8k 1.7× 568 0.7× 1.2k 2.3× 786 1.8× 126 0.3× 94 5.3k
Gilles Defer France 28 659 0.3× 526 0.6× 126 0.2× 115 0.3× 293 0.8× 104 3.2k
Gabriele Pfitzer Germany 39 2.4k 1.1× 402 0.5× 1.8k 3.4× 354 0.8× 128 0.3× 124 4.2k
Dominique Mornet France 37 3.6k 1.6× 528 0.6× 1.7k 3.4× 185 0.4× 91 0.2× 152 5.0k
Nicholas J. Izzo United States 21 1.4k 0.7× 436 0.5× 881 1.7× 634 1.5× 96 0.3× 36 3.2k
Anne d’Albis France 26 2.2k 1.0× 246 0.3× 1.3k 2.5× 258 0.6× 91 0.2× 74 3.2k

Countries citing papers authored by Albert Leung

Since Specialization
Citations

This map shows the geographic impact of Albert Leung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Albert Leung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Albert Leung more than expected).

Fields of papers citing papers by Albert Leung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Albert Leung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Albert Leung. The network helps show where Albert Leung may publish in the future.

Co-authorship network of co-authors of Albert Leung

This figure shows the co-authorship network connecting the top 25 collaborators of Albert Leung. A scholar is included among the top collaborators of Albert Leung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Albert Leung. Albert Leung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Saag, Kenneth G., T. J. de Villiers, Peter Alexandersen, et al.. (2020). Morphea-like skin lesions reported in the phase 3 Long-Term Odanacatib Fracture Trial (LOFT) in postmenopausal women with osteoporosis. Journal of the American Academy of Dermatology. 84(4). 1113–1119. 2 indexed citations
3.
4.
Duong, Le T., Albert Leung, & Bente Langdahl. (2015). Cathepsin K Inhibition: A New Mechanism for the Treatment of Osteoporosis. Calcified Tissue International. 98(4). 381–397. 64 indexed citations
5.
Cosman, Felicia, Nigel Gilchrist, Michael R. McClung, et al.. (2015). A phase 2 study of MK-5442, a calcium-sensing receptor antagonist, in postmenopausal women with osteoporosis after long-term use of oral bisphosphonates. Osteoporosis International. 27(1). 377–386. 19 indexed citations
6.
Papapoulos, Socrates E., DW Dempster, J. A. Eisman, et al.. (2013). Phase 3 Fracture Trial Of Odanacatib For Osteoporosis - Baseline Characteristics and Study Design. Osteoporosis International. 24. 3 indexed citations
7.
Bonnick, Sydney Lou, Alberto Odio, Santiago Palacios, et al.. (2013). Effects of Odanacatib on BMD and Safety in the Treatment of Osteoporosis in Postmenopausal Women Previously Treated With Alendronate: A Randomized Placebo-Controlled Trial. The Journal of Clinical Endocrinology & Metabolism. 98(12). 4727–4735. 47 indexed citations
8.
Blazar, Philip, et al.. (2013). Incidence of Displacement After Nondisplaced Distal Radial Fractures in Adults. Journal of Bone and Joint Surgery. 95(15). 1398–1402. 8 indexed citations
9.
Blazar, Philip, et al.. (2012). Incidence of Extensor Pollicis Longus Tendon Rupture After Nondisplaced Distal Radius Fractures. The Journal Of Hand Surgery. 37(5). 942–947. 78 indexed citations
10.
Langdahl, Bente, Neil Binkley, Henry G. Bone, et al.. (2012). Odanacatib in the treatment of postmenopausal women with low bone mineral density: Five years of continued therapy in a phase 2 study. Journal of Bone and Mineral Research. 27(11). 2251–2258. 133 indexed citations
11.
Resch, Heinrich, Neil Binkley, Henry G. Bone, et al.. (2012). Treatment with the cathepsin K inhibitor odanacatib in postmenopausal women with low BMD: 5year results of a phase 2 trial. Bone. 51(6). S12–S12. 8 indexed citations
12.
Soong, Maximillian, Brandon E. Earp, Gavin Bishop, Albert Leung, & Philip Blazar. (2011). Volar Locking Plate Implant Prominence and Flexor Tendon Rupture. Journal of Bone and Joint Surgery. 93(4). 328–335. 271 indexed citations
13.
Dempster, David W., J. A. Eisman, S. L. Greenspan, et al.. (2010). Phase 3 Fracture Trial of Odanacatib for Osteoporosis - Study Design. Endocrine Reviews. 31(3). 1 indexed citations
14.
Hooper, Michael, Augusto Faustino, Ian R. Reid, et al.. (2008). Randomized, active-controlled study of once-weekly alendronate 280 mg high dose oral buffered solution for treatment of Paget’s disease. Osteoporosis International. 20(1). 141–150. 6 indexed citations
15.
Cheng, Anchi, Albert Leung, D. Fellmann, et al.. (2007). Towards automated screening of two-dimensional crystals. Journal of Structural Biology. 160(3). 324–331. 33 indexed citations
16.
Devineni, Damayanthi, Donna Skee, Nicole Vaccaro, et al.. (2007). Pharmacokinetics and Pharmacodynamics of a Transdermal Contraceptive Patch and an Oral Contraceptive. The Journal of Clinical Pharmacology. 47(4). 497–509. 48 indexed citations
17.
Lanza, Frank L., Howard J. Schwartz, Hui Quan, et al.. (2002). The upper GI safety and tolerability of oral alendronate at a dose of 70 milligrams once weekly: a placebo-controlled endoscopy study. The American Journal of Gastroenterology. 97(1). 58–64. 47 indexed citations
18.
Leung, Albert, Kerstin Malmström, A Gallacher, et al.. (2002). Efficacy and Tolerability Profile of Etoricoxib in Patients with Osteoarthritis: A Randomized, Double-blind, Placebo and Active-comparator Controlled 12-Week Efficacy Trial. Current Medical Research and Opinion. 18(2). 49–58. 96 indexed citations
19.
Leung, Albert, Toshiaki Imagawa, Barbara A. Block, C Franzini-Armstrong, & Kevin P. Campbell. (1988). Biochemical and ultrastructural characterization of the 1,4-dihydropyridine receptor from rabbit skeletal muscle. Evidence for a 52,000 Da subunit.. Journal of Biological Chemistry. 263(2). 994–1001. 97 indexed citations
20.
Campbell, Kevin P., Albert Leung, & Toshiaki Imagawa. (1988). Structural Characterization of the Nitrendipine Receptor of the Voltage-Dependent Ca2+ Channel. Journal of Cardiovascular Pharmacology. 12. S86–S90. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel E. Michele Breakdown of academic impact, for papers by Eva R. Chin Breakdown of academic impact, for papers by Yoji Hakamata Breakdown of academic impact, for papers by Zhouguang Wang Breakdown of academic impact, for papers by Kunfu Ouyang Breakdown of academic impact, for papers by Gilles Defer Breakdown of academic impact, for papers by Gabriele Pfitzer Breakdown of academic impact, for papers by Dominique Mornet Breakdown of academic impact, for papers by Nicholas J. Izzo Breakdown of academic impact, for papers by Anne d’Albis
Rankless by CCL
2026